Naphthyl and Coumarinyl Biarylpiperazine Derivatives as Highly Potent Human β-Secretase Inhibitors. Design, Synthesis, and Enzymatic BACE-1 and Cell Assays
Citations Over TimeTop 10% of 2006 papers
Abstract
Twenty novel beta-secretase inhibitors containing biarylpiperazine moieties belonging to naphthyl and coumarinyl series were designed for their potential use in Alzheimer's disease therapy. Enzymatic and cell-based assays have been carried out. The biological results clearly demonstrate that specific substituents located at the N(4)-position of the piperazine ring result in excellent in vitro inhibitory potency (IC(50) values ranging between 40 and 70 nM). Variable temperature NMR and modeling studies are consistent with the obtained biological data, since these studies confirmed that introduction at the N(4)-position of the piperazine ring allows productive interactions within the BACE-1 active site, which appear to be determinative for high BACE-1 inhibitory activity. These results are of particular interest since some of the new analogues belonging to the naphthyl series are almost one log more active than the best inhibitor of the similar family recently reported.
Related Papers
- → Activation and Detoxification Enzymes: Functions and Implications(2011)39 cited
- → In Vitro-nylon Bag Method for the Estimation of Dry Matter Digestibility of Roughage in Pigs(1981)1 cited
- → Antiproliferative effect of human interferon-.GAMMA. with/without polyprenoic acid on human hepatoma cells in vitro and in nude mice.(1988)1 cited
- → Enzymatic Histochemical Studies on Primary Culture Cells from Oral Mucosa and Oral Neoplastic Tissues(1976)
- → Regulatory Mechanism of Enzyme Catabolism(1972)